Longitudinal antibody profiling after dengue reveals distinct dynamics by antibody specificity over 18 months
Bos, S.; Singh, T.; Zambrana, J. V.; Duarte, E. M.; Mercado Hernander, R. J.; Huffaker, J.; Graber, A. L.; Balmaseda, A.; Harris, E.
Show abstract
The four dengue virus serotypes (DENV1-4) co-circulate worldwide, posing major challenges for vaccine development. One key issue is that certain levels and subsets of cross-reactive antibodies can enhance disease during subsequent infection with a different DENV serotype. We defined the magnitude and kinetics of 84 antiviral antibody subsets (by isotype, subclass, antigen, and cross-reactivity) after primary versus secondary dengue, using longitudinal samples collected <1, 3, 6 and 18 months post-symptom onset from a pediatric hospital study in Nicaragua. Interestingly, we found that post-primary infection, cross-reactive IgG antibodies against the envelope protein rise, not wane, over time. Antibody kinetics varied by specificity as measured by infecting serotype versus cross-reactive subsets, viral antigen, and subdomain of a single antigen. Further, substantial seropositivity of IgA, IgM, and IgG3 at 18 months post-infection was observed. These findings highlight several novel conceptual insights into flavivirus immunity and disease risk and have implications for vaccine design and serodiagnosis.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Anamnestic Humoral Correlates of Immunity Across SARS-CoV-2 Variants of Concern 94%
- Low levels of H5N1 HA and NA antibodies in the human population are boosted by seasonal A/H1N1 infection but not by A/H3N2 infection or influenza vaccination 93%
- Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus 93%
Similar papers in this journal
- Temporally integrated single cell RNA sequencing analysis of controlled and natural primary human DENV-1 infections 94%
- DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection 94%
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 93%
Similar papers in this journal
- The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior infection history, and assay condition 96%
- Early NK-cell and T-cell dysfunction marks progression to severe dengue in patients with obesity and healthy weight 95%
- Oligomeric state of the ZIKV E protein defines protective immune responses. 94%
Similar papers in this journal
- Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses 94%
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination 93%
- Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents 93%
Similar papers in this journal
- Immunodominant structural proteins Gc and N drive T cell-mediated protection against La Crosse virus 94%
- Viral load and timing of infection define neutralization diversity to SARS-CoV-2 infection 94%
- Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.